美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Septerna, Inc.

14.43

+0.31002.20%

盘后：14.610.1840+1.28%18:49 EDT

成交量：20.23万

成交额：290.31万

市值：6.43亿

市盈率：-5.07

高：14.62

开：14.35

低：13.98

收：14.12

52周最高：28.99

52周最低：4.17

股本：4,458.51万

流通股本：1,820.27万

量比：0.61

换手率：1.11%

股息：- -

股息率：- -

每股收益(TTM):-2.8438

每股收益(LYR):-7.2588

净资产收益率：-32.78%

总资产收益率：-21.58%

市净率：1.70

市盈率(LYR):-1.99

数据加载中...

总览公司新闻公告

Septerna宣布SEP-631 1期临床试验首批参与者开始给药，该药物为治疗肥大细胞驱动疾病的口服小分子Mrgprx2负变构调节剂

Septerna股价下跌，尽管每股收益好于预期，季度亏损扩大

BUZZ-在 H.C. Wainwright 以 "买入 "开始报道后，Septerna 上涨

Septerna, Inc.6月11日成交额为509.90万美元

Septerna, Inc.6月10日成交额为477.67万美元

Septerna, Inc.6月9日成交额为387.27万美元

Septerna, Inc.6月5日成交额为1041.90万美元

Septerna, Inc.6月3日成交额为304.97万美元

Septerna, Inc.6月2日成交额为618.10万美元

Septerna, Inc.5月29日成交额为426.70万美元

Septerna, Inc.5月27日成交额为841.91万美元

Septerna, Inc.5月23日成交额为345.72万美元

Septerna, Inc.2025财年第一财季实现净利润-21.48百万美元，同比减少51.59%

Septerna, Inc.5月21日成交额为646.27万美元

Septerna, Inc.5月20日成交额为891.76万美元

Septerna, Inc.5月19日成交额为1067.40万美元

诺和诺德豪掷2亿美元，押注口服减重小分子，与Septerna共拓多靶点代谢新药版图

富国银行：维持Septerna(SEPN.US)评级，由持股观望调整至持股观望评级, 目标价由11.00美元调整至18.00美元。

Septerna, Inc.5月15日成交额为3301.74万美元

Septerna, Inc.5月14日成交额为3.78亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/SEPN/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SEPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","market":"US","secType":"STK","nameCN":"Septerna, Inc.","latestPrice":14.43,"timestamp":1757102400000,"preClose":14.12,"halted":0,"volume":202298,"hourTrading":{"tag":"盘后","latestPrice":14.614,"preClose":14.43,"latestTime":"18:49 EDT","volume":1201,"amount":17265.662,"timestamp":1757112542696},"delay":0,"floatShares":18202732,"shares":44585135,"eps":-2.843766,"marketStatus":"休市中","change":0.31,"latestTime":"09-05 16:00:00 EDT","open":14.35,"high":14.6226,"low":13.98,"amount":2903053.375538,"amplitude":0.04551,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.843766,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":7,"adr":0,"listingDate":1729828800000,"exchange":"NASDAQ","adjPreClose":14.12,"preHourTrading":{"tag":"盘前","latestPrice":14.5,"preClose":14.12,"latestTime":"09:07 EDT","volume":79,"amount":1136.419819,"timestamp":1757077652765},"postHourTrading":{"tag":"盘后","latestPrice":14.614,"preClose":14.43,"latestTime":"18:49 EDT","volume":1201,"amount":17265.662,"timestamp":1757112542696},"volumeRatio":0.6112339563408556,"impliedVol":0.6239,"impliedVolPercentile":0.2676},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SEPN\",,,,,undefined,":{"symbol":"SEPN","floatShares":18202732,"roa":"-21.58%","roe":"-32.78%","lyrEps":-7.258829,"volumeRatio":0.6112339563408556,"shares":44585135,"dividePrice":0,"high":14.6226,"amplitude":0.04551,"preClose":14.12,"low":13.98,"week52Low":4.17,"pbRate":"1.70","psRate":"886.18","week52High":28.99,"institutionHeld":0,"latestPrice":14.43,"eps":-2.843766,"divideRate":0,"volume":202298,"delay":0,"ttmEps":-2.843766,"open":14.35,"prevYearClose":22.9,"prevWeekClose":12.1,"prevMonthClose":12.1,"prevQuarterClose":10.57,"fiveDayClose":12.28,"twentyDayClose":11.7,"sixtyDayClose":10.28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SEPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-11","symbol":"SEPN","fiscalQuarterEnding":"2025/06","expectedEps":-0.05,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-0.56},{"market":"US","date":"2025-05-15","symbol":"SEPN","fiscalQuarterEnding":"2025/03","expectedEps":-0.38,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-03-27","symbol":"SEPN","fiscalQuarterEnding":"2024/12","expectedEps":-0.69,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.64}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SEPN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SEPN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.8,"hold":0.2,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1750737600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SEPN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SEPN","date":"2025-09-05","current":-7.194356,"percent":0.41784,"low":-71.269737,"twenty":-46.300716,"median":-6.581688,"eighty":-4.297053,"high":261.261398,"avg":-0.599732,"sd":73.430714,"marketCap":629542106},"quantilePoints":[{"date":"2024-10-25","current":180.873276,"twenty":180.873276,"median":180.873276,"eighty":180.873276,"marketCap":756050292},{"date":"2024-10-31","current":204.688257,"twenty":197.111676,"median":204.688257,"eighty":209.813,"marketCap":855596913},{"date":"2024-11-08","current":261.261398,"twenty":203.984861,"median":216.997688,"eighty":242.57116,"marketCap":1092072644},{"date":"2024-11-15","current":224.885772,"twenty":207.743006,"median":230.613426,"eighty":256.156752,"marketCap":940022529},{"date":"2024-11-22","current":-56.371082,"twenty":203.984861,"median":228.503238,"eighty":245.706296,"marketCap":915240881},{"date":"2024-11-29","current":-69.163916,"twenty":-57.105794,"median":221.92146,"eighty":240.581553,"marketCap":1122945345},{"date":"2024-12-06","current":-68.890433,"twenty":-66.926823,"median":208.506693,"eighty":237.707678,"marketCap":1118505070},{"date":"2024-12-13","current":-61.725172,"twenty":-67.501138,"median":191.022276,"eighty":236.763117,"marketCap":1002169886},{"date":"2024-12-20","current":-63.995083,"twenty":-66.784612,"median":-58.207863,"eighty":234.592638,"marketCap":1039024162},{"date":"2024-12-27","current":-70.449288,"twenty":-68.420042,"median":-60.166317,"eighty":232.180994,"marketCap":1143814633},{"date":"2025-01-03","current":-58.388676,"twenty":-68.655237,"median":-61.232902,"eighty":229.769351,"marketCap":947998541},{"date":"2025-01-10","current":-57.02126,"twenty":-67.714455,"median":-60.412452,"eighty":226.39305,"marketCap":925797170},{"date":"2025-01-17","current":-46.437457,"twenty":-67.358927,"median":-58.853597,"eighty":224.885772,"marketCap":753958559},{"date":"2025-01-24","current":-50.266223,"twenty":-66.593173,"median":-57.614562,"eighty":220.142874,"marketCap":816122397},{"date":"2025-01-31","current":-48.433885,"twenty":-66.401735,"median":-55.982023,"eighty":215.822012,"marketCap":786372560},{"date":"2025-02-07","current":-38.861971,"twenty":-65.110894,"median":-50.840537,"eighty":209.813,"marketCap":630962963},{"date":"2025-02-14","current":-31.587316,"twenty":-64.153703,"median":-49.199638,"eighty":205.451944,"marketCap":512851670},{"date":"2025-02-21","current":-16.108164,"twenty":-63.748948,"median":-46.492154,"eighty":202.578068,"marketCap":261532150},{"date":"2025-02-28","current":-15.862029,"twenty":-63.55204,"median":-46.410109,"eighty":188.992476,"marketCap":257535903},{"date":"2025-03-07","current":-17.393535,"twenty":-63.169163,"median":-46.191322,"eighty":63.291545,"marketCap":282401439},{"date":"2025-03-14","current":-17.47558,"twenty":-62.928498,"median":-43.237703,"eighty":-15.145503,"marketCap":283733521},{"date":"2025-03-21","current":-16.81922,"twenty":-62.747999,"median":-39.764466,"eighty":-15.424456,"marketCap":273076863},{"date":"2025-03-28","current":-3.893469,"twenty":-62.08617,"median":-37.439858,"eighty":-15.424456,"marketCap":279543299},{"date":"2025-04-04","current":-3.590162,"twenty":-61.462628,"median":-35.44343,"eighty":-3.701581,"marketCap":257766476},{"date":"2025-04-11","current":-3.194007,"twenty":-61.271189,"median":-31.04035,"eighty":-3.397655,"marketCap":229323279},{"date":"2025-04-17","current":-3.707771,"twenty":-61.249311,"median":-18.610536,"eighty":-3.429843,"marketCap":266210551},{"date":"2025-04-25","current":-3.998698,"twenty":-60.904722,"median":-17.913153,"eighty":-3.49979,"marketCap":287098524},{"date":"2025-05-02","current":-4.419614,"twenty":-60.313998,"median":-17.530277,"eighty":-3.557975,"marketCap":317319421},{"date":"2025-05-09","current":-4.302005,"twenty":-59.827198,"median":-17.393535,"eighty":-3.586448,"marketCap":308875347},{"date":"2025-05-16","current":-5.700187,"twenty":-58.946582,"median":-17.1474,"eighty":-3.607494,"marketCap":450930380},{"date":"2025-05-23","current":-5.339701,"twenty":-58.316351,"median":-16.81922,"eighty":-3.64092,"marketCap":422413044},{"date":"2025-05-30","current":-5.553739,"twenty":-57.970542,"median":-16.682479,"eighty":-3.660728,"marketCap":439345212},{"date":"2025-06-06","current":-5.925491,"twenty":-56.891224,"median":-16.203883,"eighty":-3.697867,"marketCap":468753715},{"date":"2025-06-13","current":-5.863532,"twenty":-56.29327,"median":-16.053467,"eighty":-3.717675,"marketCap":463852298},{"date":"2025-06-20","current":-5.908593,"twenty":-55.982023,"median":-15.862029,"eighty":-3.757291,"marketCap":467416965},{"date":"2025-06-27","current":-6.122632,"twenty":-53.001056,"median":-15.383433,"eighty":-3.77586,"marketCap":484349134},{"date":"2025-07-03","current":-6.404261,"twenty":-51.513306,"median":-10.750269,"eighty":-3.795668,"marketCap":506628303},{"date":"2025-07-11","current":-6.578872,"twenty":-50.660039,"median":-6.404261,"eighty":-3.874899,"marketCap":520441387},{"date":"2025-07-18","current":-7.108336,"twenty":-50.32092,"median":-6.590137,"eighty":-3.893469,"marketCap":562326225},{"date":"2025-07-25","current":-7.6378,"twenty":-49.412955,"median":-6.753482,"eighty":-3.9727,"marketCap":604211063},{"date":"2025-08-01","current":-6.990051,"twenty":-48.587036,"median":-6.961888,"eighty":-3.99746,"marketCap":552968974},{"date":"2025-08-08","current":-6.590137,"twenty":-46.8805,"median":-6.764747,"eighty":-3.998698,"marketCap":521332554},{"date":"2025-08-15","current":-5.951139,"twenty":-46.492154,"median":-6.643647,"eighty":-4.11805,"marketCap":520754376},{"date":"2025-08-22","current":-5.961329,"twenty":-46.448396,"median":-6.601402,"eighty":-4.167728,"marketCap":521646079},{"date":"2025-08-29","current":-6.256848,"twenty":-46.3937,"median":-6.581688,"eighty":-4.266238,"marketCap":547505457},{"date":"2025-09-05","current":-7.194356,"twenty":-46.300716,"median":-6.581688,"eighty":-4.297053,"marketCap":629542106}],"updateTime":1757228844839},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SEPN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1103012740","title":"Septerna宣布SEP-631 1期临床试验首批参与者开始给药，该药物为治疗肥大细胞驱动疾病的口服小分子Mrgprx2负变构调节剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1103012740","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103012740?lang=zh_cn&edition=fundamental","pubTime":"2025-08-21 20:01","pubTimestamp":1755777688,"startTime":"0","endTime":"0","summary":"Septerna公司宣布，其SEP-631药物的1期临床试验已开始为首批参与者给药。SEP-631是一种口服小分子Mrgprx2负变构调节剂，专门用于治疗由肥大细胞驱动的相关疾病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2558695834","title":"Septerna股价下跌，尽管每股收益好于预期，季度亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=2558695834","media":"英为财情","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558695834?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 04:59","pubTimestamp":1754945940,"startTime":"0","endTime":"0","summary":"Investing.com -- 专注于G蛋白偶联受体药物发现的生物技术公司Septerna, Inc. 在报告第二季度净亏损扩大的情况下，尽管盈利表现好于预期，其股价仍下跌了4.3%。季度收入为10万美元。公司净亏损从去年同期的1640万美元扩大到2480万美元，主要由于研发费用增加，同比从1500万美元增至2220万美元。Septerna还将在第三季度启动SEP-631的I期临床试验，这是一种用于肥大细胞驱动疾病的口服小分子治疗药物。截至2025年6月30日，Septerna的现金状况为3.792亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/earnings/article-93CH-2931851","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2545445729","title":"BUZZ-在 H.C. Wainwright 以 \"买入 \"开始报道后，Septerna 上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2545445729","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545445729?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 00:04","pubTimestamp":1750694675,"startTime":"0","endTime":"0","summary":"6月23日 - ** 药物开发商 Septerna SEPN.O 股价上涨 1.8%，至 10.66 美元 ** 券商H.C. Wainwright给予 \"买入 \"评级，将目标价定为26美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nL4S3SQ171:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2542056932","title":"Septerna, Inc.6月11日成交额为509.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542056932","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542056932?lang=zh_cn&edition=fundamental","pubTime":"2025-06-12 12:51","pubTimestamp":1749703908,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Septerna, Inc.成交额为509.90万美元，成交额较昨日增加6.75%，当日成交量为49.85万股。Septerna, Inc.于2025年6月11日涨0.0%，报10.28美元，该股过去5个交易日涨3.11%，年初至今跌55.11%，过去60日涨62.15%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-11|509.90万|6.75%|49.85万|#|2025-06-10|477.67万|23.34%|46.94万|#|2025-06-09|387.27万|-55.50%|38.26万|#|2025-06-06|870.29万|-16.47%|84.22万|#|2025-06-05|1041.90万|136.32%|100.31万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612125149a4a46ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612125149a4a46ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2542379513","title":"Septerna, Inc.6月10日成交额为477.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542379513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542379513?lang=zh_cn&edition=fundamental","pubTime":"2025-06-11 12:29","pubTimestamp":1749616176,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Septerna, Inc.成交额为477.67万美元，成交额较昨日增加23.34%，当日成交量为46.94万股。Septerna, Inc.于2025年6月10日涨1.68%，报10.28美元，该股过去5个交易日涨3.11%，年初至今跌55.11%，过去60日涨63.17%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-10|477.67万|23.34%|46.94万|#|2025-06-09|387.27万|-55.50%|38.26万|#|2025-06-06|870.29万|-16.47%|84.22万|#|2025-06-05|1041.90万|136.32%|100.31万|#|2025-06-04|440.88万|44.57%|43.77万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611122937a4a2e88c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611122937a4a2e88c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2542190366","title":"Septerna, Inc.6月9日成交额为387.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542190366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542190366?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 12:19","pubTimestamp":1749529166,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日，Septerna, Inc.成交额为387.27万美元，成交额较昨日减少55.50%，当日成交量为38.26万股。Septerna, Inc.于2025年6月9日跌0.98%，报10.11美元，该股过去5个交易日涨1.81%，年初至今跌55.85%，过去60日涨58.22%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-09|387.27万|-55.50%|38.26万|#|2025-06-06|870.29万|-16.47%|84.22万|#|2025-06-05|1041.90万|136.32%|100.31万|#|2025-06-04|440.88万|44.57%|43.77万|#|2025-06-03|304.97万|-50.66%|30.69万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610121938a7018ca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610121938a7018ca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2541882846","title":"Septerna, Inc.6月5日成交额为1041.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541882846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541882846?lang=zh_cn&edition=fundamental","pubTime":"2025-06-06 12:35","pubTimestamp":1749184530,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Septerna, Inc.成交额为1041.90万美元，成交额较昨日增加136.32%，当日成交量为100.31万股。Septerna, Inc.于2025年6月5日涨5.52%，报10.52美元，该股过去5个交易日涨6.69%，年初至今跌54.06%，过去60日涨57.49%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-05|1041.90万|136.32%|100.31万|#|2025-06-04|440.88万|44.57%|43.77万|#|2025-06-03|304.97万|-50.66%|30.69万|#|2025-06-02|618.10万|-17.09%|62.75万|#|2025-05-30|745.52万|74.72%|79.64万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606123535a49c5bcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606123535a49c5bcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2540769038","title":"Septerna, Inc.6月3日成交额为304.97万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540769038?lang=zh_cn&edition=fundamental","pubTime":"2025-06-04 12:27","pubTimestamp":1749011261,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日，Septerna, Inc.成交额为304.97万美元，成交额较昨日减少50.66%，当日成交量为30.69万股。Septerna, Inc.于2025年6月3日涨0.4%，报9.97美元，该股过去5个交易日涨3.32%，年初至今跌56.46%，过去60日涨55.05%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-03|304.97万|-50.66%|30.69万|#|2025-06-02|618.10万|-17.09%|62.75万|#|2025-05-30|745.52万|74.72%|79.64万|#|2025-05-29|426.70万|17.76%|43.15万|#|2025-05-28|362.34万|-56.96%|37.27万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604122751a6f9a2dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604122751a6f9a2dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2540749590","title":"Septerna, Inc.6月2日成交额为618.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540749590","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540749590?lang=zh_cn&edition=fundamental","pubTime":"2025-06-03 12:20","pubTimestamp":1748924451,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日，Septerna, Inc.成交额为618.10万美元，成交额较昨日减少17.09%，当日成交量为62.75万股。Septerna, Inc.于2025年6月2日涨7.35%，报9.93美元，该股过去5个交易日涨8.05%，年初至今跌56.64%，过去60日涨56.13%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-06-02|618.10万|-17.09%|62.75万|#|2025-05-30|745.52万|74.72%|79.64万|#|2025-05-29|426.70万|17.76%|43.15万|#|2025-05-28|362.34万|-56.96%|37.27万|#|2025-05-27|841.91万|143.52%|87.40万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603122057a497a1aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603122057a497a1aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2539214947","title":"Septerna, Inc.5月29日成交额为426.70万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539214947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539214947?lang=zh_cn&edition=fundamental","pubTime":"2025-05-30 12:19","pubTimestamp":1748578778,"startTime":"0","endTime":"0","summary":"美东时间2025年5月29日，Septerna, Inc.成交额为426.70万美元，成交额较昨日增加17.76%，当日成交量为43.15万股。Septerna, Inc.于2025年5月29日涨1.44%，报9.86美元，该股过去5个交易日涨8.83%，年初至今跌56.94%，过去60日涨60.06%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-29|426.70万|17.76%|43.15万|#|2025-05-28|362.34万|-56.96%|37.27万|#|2025-05-27|841.91万|143.52%|87.40万|#|2025-05-23|345.72万|-47.80%|37.32万|#|2025-05-22|662.31万|2.48%|70.17万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530121947a6f2b8d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530121947a6f2b8d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2538520443","title":"Septerna, Inc.5月27日成交额为841.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538520443","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538520443?lang=zh_cn&edition=fundamental","pubTime":"2025-05-28 12:21","pubTimestamp":1748406078,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日，Septerna, Inc.成交额为841.91万美元，成交额较昨日增加143.52%，当日成交量为87.40万股。Septerna, Inc.于2025年5月27日涨5.01%，报9.65美元，该股过去5个交易日跌3.21%，年初至今跌57.86%，过去60日涨49.15%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-27|841.91万|143.52%|87.40万|#|2025-05-23|345.72万|-47.80%|37.32万|#|2025-05-22|662.31万|2.48%|70.17万|#|2025-05-21|646.27万|-27.53%|70.36万|#|2025-05-20|891.76万|-16.46%|93.41万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528122120a48f393e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528122120a48f393e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2537161450","title":"Septerna, Inc.5月23日成交额为345.72万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537161450","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537161450?lang=zh_cn&edition=fundamental","pubTime":"2025-05-24 11:48","pubTimestamp":1748058513,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日，Septerna, Inc.成交额为345.72万美元，成交额较昨日减少47.80%，当日成交量为37.32万股。Septerna, Inc.于2025年5月23日跌3.06%，报9.19美元，该股过去5个交易日跌6.61%，年初至今跌59.87%，过去60日涨58.45%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-23|345.72万|-47.80%|37.32万|#|2025-05-22|662.31万|2.48%|70.17万|#|2025-05-21|646.27万|-27.53%|70.36万|#|2025-05-20|891.76万|-16.46%|93.41万|#|2025-05-19|1067.40万|-54.13%|107.99万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524114843a6eafe0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524114843a6eafe0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2537153744","title":"Septerna, Inc.2025财年第一财季实现净利润-21.48百万美元，同比减少51.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153744","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537153744?lang=zh_cn&edition=fundamental","pubTime":"2025-05-24 00:01","pubTimestamp":1748016060,"startTime":"0","endTime":"0","summary":"5月24日，Septerna, Inc.公布财报，公告显示公司2025财年第一财季净利润为-21.48百万美元，同比减少51.59%；其中营业收入为219000.00美元，同比减少30.91%，每股基本收益为-0.49美元。从资产负债表来看，Septerna, Inc.总负债33.75百万美元，其中短期债务1.94百万美元，资产负债比为0.13，流动比率为0.33。机构评级：截至2025年5月24日，当前有3家机构对Septerna, Inc.目标价做出预测，其中目标均价为23.67美元，其中最低目标价为18.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000141a6ea7d3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524000141a6ea7d3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN"],"gpt_icon":0},{"id":"2537096038","title":"Septerna, Inc.5月21日成交额为646.27万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537096038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537096038?lang=zh_cn&edition=fundamental","pubTime":"2025-05-22 11:51","pubTimestamp":1747885863,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日，Septerna, Inc.成交额为646.27万美元，成交额较昨日减少27.53%，当日成交量为70.36万股。Septerna, Inc.于2025年5月21日跌3.82%，报9.06美元，该股过去5个交易日跌10.83%，年初至今跌60.44%，过去60日涨64.13%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-21|646.27万|-27.53%|70.36万|#|2025-05-20|891.76万|-16.46%|93.41万|#|2025-05-19|1067.40万|-54.13%|107.99万|#|2025-05-16|2326.87万|-29.53%|233.42万|#|2025-05-15|3301.74万|-91.26%|336.04万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522115104a6e84205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522115104a6e84205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2537822674","title":"Septerna, Inc.5月20日成交额为891.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537822674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537822674?lang=zh_cn&edition=fundamental","pubTime":"2025-05-21 11:41","pubTimestamp":1747798910,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日，Septerna, Inc.成交额为891.76万美元，成交额较昨日减少16.46%，当日成交量为93.41万股。Septerna, Inc.于2025年5月20日跌5.52%，报9.42美元，该股过去5个交易日涨39.97%，年初至今跌58.86%，过去60日涨64.4%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-20|891.76万|-16.46%|93.41万|#|2025-05-19|1067.40万|-54.13%|107.99万|#|2025-05-16|2326.87万|-29.53%|233.42万|#|2025-05-15|3301.74万|-91.26%|336.04万|#|2025-05-14|3.78亿|24652.34%|3781.58万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521114155a4862acd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521114155a4862acd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0},{"id":"2536665722","title":"Septerna, Inc.5月19日成交额为1067.40万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536665722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536665722?lang=zh_cn&edition=fundamental","pubTime":"2025-05-20 11:30","pubTimestamp":1747711837,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日，Septerna, Inc.成交额为1067.40万美元，成交额较昨日减少54.13%，当日成交量为107.99万股。Septerna, Inc.于2025年5月19日涨1.32%，报9.97美元，该股过去5个交易日涨42.84%，年初至今跌56.46%，过去60日涨71.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-19|1067.40万|-54.13%|107.99万|#|2025-05-16|2326.87万|-29.53%|233.42万|#|2025-05-15|3301.74万|-91.26%|336.04万|#|2025-05-14|3.78亿|24652.34%|3781.58万|#|2025-05-13|152.53万|0.72%|22.79万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520113046a484d32d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520113046a484d32d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2536372954","title":"诺和诺德豪掷2亿美元，押注口服减重小分子，与Septerna共拓多靶点代谢新药版图","url":"https://stock-news.laohu8.com/highlight/detail?id=2536372954","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536372954?lang=zh_cn&edition=fundamental","pubTime":"2025-05-17 12:13","pubTimestamp":1747455180,"startTime":"0","endTime":"0","summary":"诺和诺德与Septerna达成合作协议，以2亿美元预付款获取口服小分子药物全球开发与商业化权利，意在与礼来在口服代谢药物市场上竞争，这些药物可靶向GLP-1、GIP和胰高血糖素等热门靶点，标志着诺和诺德在口服多靶点疗法方向的战略前移。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051712152194f99edb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051712152194f99edb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","LU1093756325.SGD","BK4599","BK4007","NVO","LU1093756168.USD","SEPN","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","IE00BZ1G4Q59.USD"],"gpt_icon":0},{"id":"2535137223","title":"富国银行：维持Septerna(SEPN.US)评级，由持股观望调整至持股观望评级, 目标价由11.00美元调整至18.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535137223","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535137223?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 21:44","pubTimestamp":1747403093,"startTime":"0","endTime":"0","summary":"富国银行：维持Septerna(SEPN.US)评级，由持股观望调整至持股观望评级, 目标价由11.00美元调整至18.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/16214450462951.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["SEPN"],"gpt_icon":0},{"id":"2535335605","title":"Septerna, Inc.5月15日成交额为3301.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535335605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535335605?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 11:28","pubTimestamp":1747366108,"startTime":"0","endTime":"0","summary":"美东时间2025年5月15日，Septerna, Inc.成交额为3301.74万美元，成交额较昨日减少91.26%，当日成交量为336.04万股。Septerna, Inc.于2025年5月15日跌0.39%，报10.12美元，该股过去5个交易日涨45.61%，年初至今跌55.81%，过去60日涨82.34%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-15|3301.74万|-91.26%|336.04万|#|2025-05-14|3.78亿|24652.34%|3781.58万|#|2025-05-13|152.53万|0.72%|22.79万|#|2025-05-12|151.44万|35.65%|21.75万|#|2025-05-09|111.64万|-34.57%|16.48万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516112834a4805bb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516112834a4805bb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SEPN"],"gpt_icon":0},{"id":"2535185937","title":"Septerna, Inc.5月14日成交额为3.78亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535185937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535185937?lang=zh_cn&edition=fundamental","pubTime":"2025-05-15 11:20","pubTimestamp":1747279245,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日，Septerna, Inc.成交额为3.78亿美元，成交额较昨日增加24652.34%，当日成交量为3781.58万股。Septerna, Inc.于2025年5月14日涨50.97%，报10.16美元，该股过去5个交易日涨44.11%，年初至今跌55.63%，过去60日涨47.89%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-14|3.78亿|24652.34%|3781.58万|#|2025-05-13|152.53万|0.72%|22.79万|#|2025-05-12|151.44万|35.65%|21.75万|#|2025-05-09|111.64万|-34.57%|16.48万|#|2025-05-08|170.61万|38.07%|24.31万|Septerna Inc 是一家临床阶段的生物技术公司，开创了G蛋白偶联受体口服小分子药物发现的新时代，该公司拥有专有的天然复合物平台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515112053a6dfc529&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515112053a6dfc529&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SEPN","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":57,"code":"91000000","status":"200"}]}}